http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02102985-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ddde905e0055ab1a38be9d327e143b75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a14c3b5a4e1f34cfb2066f09583655cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a933a0dd561e3e50b278738704d5c6e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa49d942d13eabbbd1878912d1a24318 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0100c26dd0a54a962583a7e1a37b8f9e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_546e9ccf59572045315cad7760e24500 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3069 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 |
| filingDate | 2002-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0717a1a9dbd42910527b181a04353d32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c25d313ceb526fc842c49ceb08cf7eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75591df03504b33969425b1757f037f8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_901213f242f186a7bd77ada90bfd51c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f0a2a873e5fe28ed0d0a49c041b13bb |
| publicationDate | 2002-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-02102985-A2 |
| titleOfInvention | Pate, a gene expressed in prostate cancer, prostate and testis, and uses thereof |
| abstract | An antibody is disclosed that specifically binds a PATE polypeptide. A nucleic acid sequence is disclosed that includes a PATE promoter or a conservative variant thereof. Methods are also disclosed for detecting prostate cancer in a subject. In one embodiment, a method is disclosed for producing an immune response against a cell expressing a PATE polypeptide in a subject. In another embodiment, a method is disclosed for inhibiting the growth of a malignant cell expressing a PATE polypeptide. A method is also disclosed for reducing the number of prostate cancer cells in a subject that includes administering to the subject a therapeutically effective amount of the PATE polypeptide or a polynucleotide encoding the PATE polypeptide. Kits for detecting PATE polypeptides and PATE polynucleotides are disclosed. In one embodiment, these kits are ofuse to detect prostate cancer. A method is also disclosed for increasing the proliferation of a prostate cell. The method includes contacting the prostate cell with a PATE polypeptide or transfecting the prostate cell with a nucleic acid encoding the P ATE polypeptide, thereby increasing the proliferation of the prostate cell. |
| priorityDate | 2001-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 785.